5. Drug Discrimination and In Vivo Structure–Activity Relationships

  1. Richard A. Glennon and
  2. Richard Young

Published Online: 24 OCT 2011

DOI: 10.1002/9781118023150.ch5

Drug Discrimination: Applications to Medicinal Chemistry and Drug Studies

Drug Discrimination: Applications to Medicinal Chemistry and Drug Studies

How to Cite

Glennon, R. A. and Young, R. (eds) (2011) Drug Discrimination and In Vivo Structure–Activity Relationships, in Drug Discrimination: Applications to Medicinal Chemistry and Drug Studies, John Wiley & Sons, Inc., Hoboken, NJ, USA. doi: 10.1002/9781118023150.ch5

Editor Information

  1. Virginia Commonwealth University Richmond, Virginia, USA

Publication History

  1. Published Online: 24 OCT 2011
  2. Published Print: 5 AUG 2011

ISBN Information

Print ISBN: 9780470433522

Online ISBN: 9781118023150

SEARCH

Keywords:

  • DD structure-activity relationships;
  • QSAR studies;
  • nACh receptor agents

Summary

This chapter contains sections titled:

  • Structure–Activity Caveats

  • Phenylalkylamine Hallucinogens and Stimulants

  • Benzodiazepines

  • Neuronal Nicotinic Acetylcholinergic Receptor Agents

  • Aminotetralins